Insider Trading & Ownership - AVENUE THERAPEUTICS INC. (ATXI)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for AVENUE THERAPEUTICS INC.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-12-02
Sale
2024-12-03
4:30 pm
AVENUE THERAPEUTICS INC. ATXI Herskowitz Neil
Director
23 $2 $46 97
(Direct)
View
2024-11-05
Sale
2024-11-07
7:12 pm
AVENUE THERAPEUTICS INC. ATXI KRANZLER JAY D
Director
61 $2.24 $137 559
(Direct)
View
2024-09-27
Purchase
2024-10-01
4:15 pm
AVENUE THERAPEUTICS INC. ATXI KRANZLER JAY D
Director
500 $2.4994 $1,250 620
(Direct)
View
2023-12-11
Sale
2023-12-13
4:02 pm
AVENUE THERAPEUTICS INC. ATXI Davidow Robert L
10% Owner
617,000 $0.14029 $86,560 761,000
(Indirect
Direct)
View
2023-09-08
Purchase
2023-09-12
09:03 am
AVENUE THERAPEUTICS INC. ATXI ROSENWALD LINDSAY A MD
Director
348,675 $0.72 $251,046 354,318
(Direct)
View
2023-09-08
Purchase
2023-09-12
09:02 am
AVENUE THERAPEUTICS INC. ATXI Fortress Biotech Inc.
10% Owner
418,410 $0.72 $301,255 1,032,390
(Direct)
View
2022-10-11
Sale
2022-10-13
8:52 pm
AVENUE THERAPEUTICS INC. ATXI InvaGen Pharmaceuticals Inc.
10% Owner
388,888 $7.714 $2,999,882 0
(Indirect
Direct)
View
2021-09-15
Sale
2021-09-15
4:03 pm
AVENUE THERAPEUTICS INC. ATXI Vazzano Joseph Walter
Chief Financial Officer
7,160 $1.62 $11,599 65,252
(Direct)
View
2021-05-06
Purchase
2021-05-07
08:02 am
AVENUE THERAPEUTICS INC. ATXI Herskowitz Neil
Director
2,500 $3.99 $9,975 134,724
(Direct)
View
2020-08-20
Sale
2020-08-21
4:15 pm
AVENUE THERAPEUTICS INC. ATXI Vazzano Joseph Walter
Chief Financial Officer
3,840 $12.13 $46,579 57,412
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-03-31
Option Award
2025-04-02
4:05 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI Fortress Biotech Inc.
10% Owner
33,724 $0 328,524
(Direct)
View

Ownership
2025-01-03
4:21 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI Fortress Biotech Inc.
10% Owner
0 $0 294,800
(Direct)
View
2024-09-23
Option Award
2024-09-25
4:59 pm
N/A
2034-09-23
AVENUE THERAPEUTICS INC. ATXI ROSENWALD LINDSAY A MD
Director
30,000 $0 30,000
(Direct)
View
2024-09-23
Option Award
2024-09-25
4:57 pm
N/A
2034-09-23
AVENUE THERAPEUTICS INC. ATXI Herskowitz Neil
Director
30,000 $0 30,000
(Direct)
View
2024-09-23
Option Award
2024-09-25
4:55 pm
N/A
2034-09-23
AVENUE THERAPEUTICS INC. ATXI Oltmans Curtis Gale
Director
30,000 $0 30,000
(Direct)
View
2024-09-23
Option Award
2024-09-25
4:55 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI MacLean Alexandra
Chief Executive Officer
170,000 $0 170,000
(Direct)
View
2024-09-23
Option Award
2024-09-25
4:54 pm
N/A
2034-09-23
AVENUE THERAPEUTICS INC. ATXI KRANZLER JAY D
Director
30,000 $0 30,000
(Direct)
View
2024-09-23
Option Award
2024-09-25
4:53 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI Jin David
Interim PFO and COO
65,000 $0 65,000
(Direct)
View
2024-09-23
Option Award
2024-09-25
4:53 pm
N/A
2034-09-23
AVENUE THERAPEUTICS INC. ATXI Charles Faith L.
Director
30,000 $0 30,000
(Direct)
View
2024-04-16
Option Award
2024-04-17
4:05 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI Fortress Biotech Inc.
10% Owner
413,507 $0 3,547,393
(Direct)
View
2024-01-02
Option Award
2024-01-03
4:27 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI Fortress Biotech Inc.
10% Owner
2,101,496 $0 3,133,886
(Direct)
View

Ownership
2023-11-28
4:01 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI Davidow Robert L
10% Owner
0 $0 1,926,800
(Direct)
View
2023-06-30
Option Award
2023-07-05
4:10 pm
N/A
2033-06-30
AVENUE THERAPEUTICS INC. ATXI Charles Faith L.
Director
100,000 $0 100,000
(Direct)
View
2023-06-30
Option Award
2023-07-05
4:09 pm
N/A
2033-06-30
AVENUE THERAPEUTICS INC. ATXI Jin David
Interim PFO and COO
250,000 $0 250,000
(Direct)
View
2023-06-30
Option Award
2023-07-05
4:08 pm
N/A
2033-06-30
AVENUE THERAPEUTICS INC. ATXI ROSENWALD LINDSAY A MD
Director
100,000 $0 100,000
(Direct)
View
2023-06-30
Option Award
2023-07-05
4:08 pm
N/A
2033-06-30
AVENUE THERAPEUTICS INC. ATXI KRANZLER JAY D
Director
100,000 $0 100,000
(Direct)
View
2023-06-30
Option Award
2023-07-05
4:07 pm
N/A
2033-06-30
AVENUE THERAPEUTICS INC. ATXI Oltmans Curtis Gale
Director
100,000 $0 100,000
(Direct)
View
2023-06-30
Option Award
2023-07-05
4:07 pm
N/A
2033-06-30
AVENUE THERAPEUTICS INC. ATXI Herskowitz Neil
Director
100,000 $0 100,000
(Direct)
View
2023-06-29
Option Award
2023-07-03
1:05 pm
N/A
2033-06-29
AVENUE THERAPEUTICS INC. ATXI MacLean Alexandra
Chief Executive Officer
800,000 $0 800,000
(Direct)
View
2023-03-31
Option Award
2023-04-04
4:08 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI Fortress Biotech Inc.
10% Owner
52,419 $0 613,980
(Direct)
View
2022-12-31
Option Award
2023-01-04
5:49 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI Fortress Biotech Inc.
10% Owner
322,225 $0 811,561
(Direct)
View
2021-12-17
Option Award
2021-12-21
4:26 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI KRANZLER JAY D
Director
69,020 $0 133,683
(Direct)
View
2021-12-17
Option Award
2021-12-21
4:26 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI Herskowitz Neil
Director
69,020 $0 183,744
(Direct)
View
2021-12-17
Option Award
2021-12-21
4:24 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI Oltmans Curtis Gale
Director
49,020 $0 49,020
(Direct)
View
2021-12-17
Option Award
2021-12-20
5:08 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI Lu Lucy
President, CEO
411,616 $0 748,949
(Direct)
View
2021-12-17
Option Award
2021-12-20
5:07 pm
N/A
N/A
AVENUE THERAPEUTICS INC. ATXI Vazzano Joseph Walter
Chief Financial Officer
100,505 $0 165,757
(Direct)
View
Goto 0, 1, Next